3
1. 7. 2022.
Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm.
Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više